Pseudomonas aeruginosa elastase disrupts the cortisol-binding activity of corticosteroid-binding globulin

Endocrinology

Volumn 155, Issue 8, 2014, Pages 2900-2908

  Simard, Marc ^a   Hill, Lesley A ^a   Underhill, Caroline M ^a   Keller, Bernd O ^b   Villanueva, Ivan ^a   Hancock, Robert E W ^a   Hammond, Geoffrey L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEINS; CULTURE MEDIA, CONDITIONED; HUMANS; HYDROCORTISONE; HYDROGEN-ION CONCENTRATION; LEUKOCYTE ELASTASE; METALLOENDOPEPTIDASES; PSEUDOMONAS AERUGINOSA; TEMPERATURE; TOSYLLYSINE CHLOROMETHYL KETONE; TRANSCORTIN; VIRULENCE FACTORS; ZINC;

EID: 84905040924     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1055     Document Type: Article

References (43)

1. Hammond GL, Smith CL, Goping IS, et al. Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitors. Proc Natl Acad Sci USA. 1987; 84:5153-5157.
2. Law RH, Zhang Q, McGowan S, et al. An overview of the serpin superfamily. Genome Biol. 2006; 7:216.
3. Siiteri PK, Murai JT, Hammond GL, Nisker J.A., Raymoure WJ, Kuhn RW. The serum transport of steroid hormones. Recent Prog Horm Res. 1982; 38:457-510.
4. Lin HY, Muller YA, Hammond GL. Molecular and structural basis of steroid hormone binding and release from corticosteroid-binding globulin. Mol Cell Endocrinol. 2010; 316:3-12.
5. Pemberton PA, Stein PE, Pepys MB, Potter J.M., Carrell RW. Hormone binding globulins undergo serpin conformational change in inflammation. Nature. 1988; 336:257-258.
6. Hammond GL, Smith CL, Paterson NA, Sibbald WJ. A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils. J Clin Endocrinol Metab. 1990; 71:34-39.
7. Lin HY, Underhill C, Gardill BR, Muller Y.A., Hammond GL. Residues in the human corticosteroid-binding globulin reactive center loop that influence steroid binding beforeand after elastase cleavage. J Biol Chem. 2009; 284:884-896.
8. Westphal U. Corticosteroid-binding globulin. A review of some recent aspects. Mol Cell Biochem. 1983; 55:145-157.
9. Cameron A, Henley D, Carrell R, Zhou A., Clarke A, Lightman S. Temperature-responsive release of cortisol from its binding globulin: a protein thermocouple. J Clin Endocrinol Metab. 2010; 95: 4689-4695.
10. Gardill BR, Vogl MR, Lin HY, Hammond G.L., Muller YA. Corti-costeroid-binding globulin: structure-function implications from species differences. PLoS One. 2012; 7:e52759.
11. Hill RE, Hastie ND. Accelerated evolution in the reactive centre regions of serine protease inhibitors. Nature. 1987; 326:96-99.
12. Rapala-Kozik M, Potempa J, Nelson D, Kozik A., Travis J. Comparative cleavage sites within the reactive-site loop of native and oxidized alpha1-proteinase inhibitor by selected bacterial protein-ases. Biol Chem. 1999; 380:1211-1216.
13. Ciofu O, Hansen CR, Høiby N. Respiratory bacterial infections in cystic fibrosis. Curr Opin Pulm Med. 2013; 19:251-258.
14. Rafla K, Tredget EE. Infection control in the burn unit. Burns. 2011; 37:5-15.
15. Pugeat M, Bonneton A, Perrot D, et al. Decreased immunoreactivity and binding activity of corticosteroid-binding globulin in serum in septic shock. Clin Chem. 1989; 35:1675-1679.
16. Bernier J, Jobin N, Emptoz-Bonneton A, Pugeat MM, Garrel DR. Decreased corticosteroid-binding globulin in burn patients: relationship with interleukin-6 and fat in nutritional support. Crit Care Med. 1998; 26:452-460.
17. Hammond GL, Lähteenmäki PL. A versatile method for the determination of serum cortisol binding globulin and sex hormone binding globulin binding capacities. Clin Chim Acta. 1983; 132:101-110.
18. Robinson PA, Langley MS, Hammond GL. A solid-phase radioim-munoassay for human corticosteroid binding globulin. J Endocri-nol. 1985; 104:259-267.
19. Jacobs MA, Alwood A, Thaipisuttikul I., et al. Comprehensive trans-poson mutant library of Pseudomonas aeruginosa. Proc Natl Acad Sci USA. 2003; 100:14339-14344.
20. Engel LS, Hill JM, Caballero AR, Green L.C., O'Callaghan RJ. Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa. J Biol Chem. 1998; 273:16792-16797.
21. Caballero AR, Moreau JM, Engel LS, Marquart M.E., Hill JM, O'Callaghan RJ. Pseudomonas aeruginosa protease IV enzyme assays and comparison to other Pseudomonas proteases. Anal Biochem. 2001; 290:330-337.
22. Lebrun I, Marques-Porto R, Pereira AS, Pereira A, Perpetuo EA. Bacterial toxins: an overview on bacterial proteases and their action as virulence factors. Mini Rev Med Chem. 2009; 9:820-828.
23. Bleves S, Viarre V, Salacha R, Michel G.P., Filloux A., Voulhoux R. Protein secretion systems in Pseudomonas aeruginosa: A wealth of pathogenic weapons. Int J Med Microbiol. 2010; 300:534-543.
24. Morihara K. Pseudolysin and other pathogen endopeptidases of thermolysin family. Methods Enzymol. 1995; 248:242-253.
25. Cathcart GR, Quinn D, Greer B, et al. Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseu-domonal infection. Antimicrob Agents Chemother. 2011; 55:2670-2678.
26. Azghani AO, Bedinghaus T, Klein R. Detection of elastase from Pseudomonas aeruginosa in sputum and its potential role in epithelial cell permeability. Lung. 2000; 178:181-189.
27. Leduc D, Beaufort N, de Bentzmann S, et al. The Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor through domain-specific endo-proteolysis. Infect Immun. 2007; 75:3848-3858.
28. Kamath S, Kapatral V, Chakrabarty AM. Cellular function of elas-tase in Pseudomonas aeruginosa: role in the cleavage of nucleoside diphosphate kinase and in alginate synthesis. Mol Microbiol. 1998; 30:933-941.
29. Fullagar JL, Garner AL, Struss AK, et al. Antagonism of a zinc metalloprotease using a unique metal-chelating scaffold: tropolones as inhibitors of P. aeruginosa elastase. Chem Commun (Camb). 2013; 49:3197-3199.
30. Miyoshi S, Shinoda S. Microbial metalloproteases and pathogenesis. Microbes Infect. 2000; 2:91-98.
31. Sumer-Bayraktar Z, Kolarich D, Campbell MP, Ali S, Packer N.H., Thaysen-Andersen M. N-glycans modulate the function of human corticosteroid-binding globulin. Mol Cell Proteomics. 2011; 10: M111.009100.
32. Armstrong PB. Proteases and protease inhibitors: a balance of activities in host-pathogen interaction. Immunobiology. 2006; 211: 263-281.
33. Sharpe JR, Booth S, Jubin K, Jordan N.R., Lawrence-Watt DJ, Dheansa BS. Progression of wound pH during the course of healing in burns. J Burn Care Res. 2013; 34:e201-e208.
34. McShane D, Davies JC, Davies MG, Bush A, Geddes D.M., Alton EW. Airway surface pH in subjects with cystic fibrosis. Eur Respir J. 2003; 21:37-42.
35. Bjarnsholt T, Kirketerp-Møller K, Jensen PØ, et al. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen. 2008; 16:2-10.
36. Nichols DP, Caceres S, Caverly L, et al. Effects of azithromycin in Pseudomonas aeruginosa burn wound infection. J Surg Res. 2013; 183:767-776.
37. van Delden C. Pseudomonas aeruginosa bloodstream infections: how should we treat them? Int J Antimicrob Agents. 2007; 30 Suppl 1:S71-S75.
38. Roux D, Ricard JD. Novel therapies for Pseudomonas aeruginosa pneumonia. Infect Disord Drug Targets. 2011; 11:389-394.
39. Gellatly SL, Hancock RE. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis. 2013; 67:159-173.
40. Morihara K, Tsuzuki H, Harada M., Iwata T. Purification of human plasma alpha 1-proteinase inhibitor and its inactivation by Pseudomonas aeruginosa elastase. J Biochem. 1984; 95:795-804.
41. Taggart C, Cervantes-Laurean D, Kim G, et al. Oxidation of either methionine 351ormethionine 358inalpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J Biol Chem. 2000; 275:27258-27265.
42. Jimenez PN, Koch G, Thompson JA, Xavier K.B., Cool RH, Quax WJ. The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. Microbiol Mol Biol Rev. 2012; 76:46-65.
43. Annane D, Cavaillon JM. Corticosteroids in sepsis: from bench to bedside? Shock. 2003; 20:197-207.